TAIHUSNOW CO.,LTD.
838262
Guangdong Brandmax Marketing
300805
Guangdong Transtek Medical Electronics
300562
Suzhou Kingswood Education Technology
300192
Broadex Technologies
300548
CN Stock MarketDetailed Quotes
300511 Shanghai Xuerong Bio-Technology
- 4.50
- +0.01+0.22%
Trading Dec 16 13:18 CST
2.24BMarket Cap-10.02P/E (TTM)
4.63High4.47Low201.61KlotVolume4.47Open4.49Pre Close91.78MTurnover4.82%Turnover RatioLossP/E (Static)498.82MShares5.4452wk High1.70P/B1.88BFloat Cap2.4052wk Low5.39Limit Up418.04MShs Float27.00Historical High3.59Limit Down3.56%Amplitude2.40Historical Low--Dividend TTM4.55Avg Price91.03KlotAsk--Div YieldTTM100Lot Size108.28KlotBid
Shanghai Xuerong Bio-Technology Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | -15.79%1.63B | -21.14%1.08B | -25.46%613.31M | 9.59%2.55B | 17.81%1.94B | 40.63%1.37B | 48.75%822.75M | 12.61%2.32B | 15.17%1.65B | 4.52%973.5M |
| Refunds of taxes and levies | ---- | ---- | ---- | -76.35%36.66K | ---- | ---- | ---- | --155.03K | --655.74K | --12.89K |
| Cash received relating to other operating activities | -19.66%45.29M | -13.02%33.6M | -43.48%11.96M | 33.21%47.8M | 34.02%56.37M | 6.85%38.63M | 45.85%21.16M | -7.44%35.88M | -9.58%42.06M | 64.41%36.16M |
| Cash inflows from operating activities | -15.90%1.68B | -20.91%1.11B | -25.91%625.26M | 9.94%2.59B | 18.17%2B | 39.42%1.41B | 48.68%843.91M | 12.25%2.36B | 14.44%1.69B | 5.91%1.01B |
| Goods services cash paid | -22.48%953.53M | -13.94%697.75M | -0.32%364.77M | 5.09%1.56B | 11.84%1.23B | 9.86%810.82M | -7.92%365.94M | 10.36%1.48B | 13.98%1.1B | 23.83%738.06M |
| Staff behalf paid | -5.64%410.59M | 0.96%286.5M | 1.96%148.94M | 33.66%567.35M | 28.68%435.11M | 18.44%283.78M | 30.92%146.07M | -3.11%424.48M | -6.95%338.13M | -3.65%239.6M |
| All taxes paid | 4.11%17.66M | 5.92%12.88M | -7.08%4.86M | -5.00%21.21M | 11.83%16.96M | 15.45%12.16M | 9.67%5.23M | 15.99%22.32M | 28.01%15.17M | 24.37%10.54M |
| Cash paid relating to other operating activities | -36.21%63.34M | -30.44%47.29M | -13.73%27.07M | 41.35%91.03M | 63.91%99.29M | 89.69%67.98M | 77.96%31.38M | 15.37%64.4M | -7.84%60.58M | -25.96%35.84M |
| Cash outflows from operating activities | -18.88%1.45B | -11.09%1.04B | -0.54%545.64M | 12.24%2.24B | 17.69%1.78B | 14.72%1.17B | 3.24%548.62M | 7.39%1.99B | 7.67%1.51B | 13.58%1.02B |
| Net cash flows from operating activities | 8.69%234.49M | -70.44%68.86M | -73.04%79.62M | -2.53%357.84M | 22.33%215.73M | 1,722.25%232.94M | 715.55%295.29M | 48.79%367.13M | 148.46%176.35M | -127.72%-14.36M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | -98.86%5.35M | -98.88%5.27M | -98.45%4.18M | --471.05M | 81.08%470.8M | --470M | --270M | ---- | -61.70%260M | ---- |
| Cash received from returns on investments | ---- | ---- | ---- | -23.96%1.51M | 179.67%1.55M | --1.55M | --1.16M | 5.26%1.99M | -70.60%552.56K | ---- |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | -68.38%10.21M | -68.20%10.1M | 3,577.61%9.72M | -21.58%69.23M | -58.17%32.29M | -58.67%31.75M | -86.19%264.17K | 45.68%88.28M | 250.03%77.21M | 444.69%76.81M |
| Net cash received from disposal of subsidiaries and other business units | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --78M | ---- | ---- |
| Cash received relating to other investing activities | ---- | ---- | ---- | ---- | ---- | ---- | --73M | ---- | ---- | ---- |
| Cash inflows from investing activities | -96.92%15.57M | -96.95%15.36M | -95.97%13.89M | 221.98%541.79M | 49.41%504.64M | 555.22%503.29M | 17,911.73%344.43M | 169.27%168.27M | -51.94%337.76M | -88.62%76.81M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -61.70%302.86M | -29.32%267.05M | 54.04%225.13M | 243.39%1.1B | 255.44%790.7M | 130.02%377.81M | 39.76%146.15M | -50.07%319.47M | -57.48%222.46M | -52.59%164.25M |
| Cash paid to acquire investments | ---- | ---- | ---- | -26.47%200M | ---- | ---- | ---- | 1,260.00%272M | -86.50%4M | --2M |
| Cash paid relating to other investing activities | -99.99%14K | ---- | ---- | ---- | -58.29%200.19M | 100.00%200M | --50M | ---- | -28.90%479.93M | -85.19%100M |
| Cash outflows from investing activities | -69.43%302.87M | -53.78%267.05M | 14.78%225.13M | 119.29%1.3B | 40.28%990.89M | 117.01%577.81M | 87.57%196.15M | -10.37%591.47M | -42.46%706.38M | -73.93%266.25M |
| Net cash flows from investing activities | 40.91%-287.31M | -237.74%-251.68M | -242.46%-211.24M | -78.46%-755.24M | -31.91%-486.25M | 60.66%-74.52M | 244.43%148.28M | 29.16%-423.21M | 29.77%-368.62M | 45.34%-189.44M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | --226.78K | --134.7K | --2.05M | ---- | ---- | ---- | ---- | 1,577.00%386.73M | 1,587.79%388.99M | 2,462.91%388.99M |
| Cash from borrowing | -6.29%1.03B | 70.27%949.88M | 196.33%807.48M | 31.89%1.2B | 35.66%1.1B | -19.97%557.88M | 2.18%272.49M | -1.80%910.94M | 12.86%814.06M | 56.66%697.1M |
| Cash received relating to other financing activities | 345.29%53.43M | 435.21%53.52M | 1,566.67%50M | -74.40%18.29M | -80.96%12M | -82.47%10M | -94.60%3M | 539.55%71.44M | --63.03M | --57.03M |
| Cash inflows from financing activities | -2.49%1.09B | 76.72%1B | 211.99%859.53M | -10.91%1.22B | -11.83%1.12B | -50.32%567.88M | -61.26%275.49M | 42.34%1.37B | 70.09%1.27B | 148.42%1.14B |
| Borrowing repayment | 38.27%937.63M | -9.15%542.92M | -33.14%222.01M | -24.77%895.53M | -21.84%678.1M | -5.55%597.63M | 35.06%332.07M | 32.06%1.19B | 38.42%867.56M | 15.88%632.73M |
| Dividend interest payment | 35.40%53.9M | 51.25%40.39M | 50.70%15.48M | 2.71%60.32M | -12.46%39.81M | -16.58%26.71M | -29.19%10.27M | -42.76%58.73M | -52.70%45.48M | -61.04%32.02M |
| Cash payments relating to other financing activities | -24.64%39.4M | -72.45%14.41M | ---- | 12.08%59.23M | 33.32%52.29M | 44.09%52.29M | 115.99%33.92M | 100.74%52.85M | 201.70%39.22M | 201.31%36.29M |
| Cash outflows from financing activities | 33.85%1.03B | -11.66%597.73M | -36.88%237.49M | -22.04%1.02B | -19.12%770.19M | -3.48%676.62M | 36.29%376.27M | 26.37%1.3B | 29.40%952.25M | 9.49%701.04M |
| Net cash flows from financing activities | -83.36%57.61M | 473.20%405.81M | 717.27%622.03M | 205.00%204.65M | 10.30%346.17M | -124.60%-108.74M | -123.16%-100.77M | 197.96%67.1M | 3,620.84%313.83M | 345.49%442.09M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | 636.56%3.57M | 77.84%-222.21K | -1,860.28%-1.31M | -6.83%146.47K | -10,089.02%-665.07K | -7,328.38%-1M | -153.28%-66.93K | 111.56%157.22K | 100.18%6.66K | -100.99%-13.5K |
| Net increase in cash and cash equivalents | -88.85%8.36M | 357.65%222.77M | 42.71%489.1M | -1,822.14%-192.6M | -38.32%74.99M | -79.57%48.68M | -7.03%342.73M | 102.66%11.18M | 127.07%121.57M | 150.32%238.27M |
| Add:Begin period cash and cash equivalents | -54.94%157.96M | -54.94%157.96M | -54.94%157.96M | 3.30%350.56M | 3.30%350.56M | 3.30%350.56M | 3.30%350.56M | -55.34%339.38M | -55.34%339.38M | -55.34%339.38M |
| End period cash equivalent | -60.92%166.32M | -4.64%380.73M | -6.67%647.06M | -54.94%157.96M | -7.68%425.55M | -30.89%399.24M | -2.08%693.29M | 3.30%350.56M | 48.32%460.95M | 101.74%577.65M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Ernst & Young Huaming Certified Public Accountants (Special General Partnership) | -- | -- | -- | Ernst & Young Huaming Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
